Zobrazeno 1 - 10
of 263
pro vyhledávání: '"E R Froesch"'
Autor:
E. R. Froesch
Publikováno v:
Acta Medica Scandinavica. 192:239-244
Autor:
E. R. Froesch
Publikováno v:
Acta Medica Scandinavica. 192:37-46
The rate limiting step of fructose metabolism in adipose tissue is fructose transport into the cell. The step is accelerated by insulin only in the absence of glucose, so that insulin has no effect on fructose transport under physiologic conditions.
Autor:
E. R. Froesch, J. Zapf
Publikováno v:
Comprehensive Physiology
The sections in this article are: 1 Indirect Evidence that Insulin-Like Growth Factor I Participates in the Regulation of Somatic Growth 1.1 Clinical: Correlations Between Growth and Insulin-Like Growth Factor I Levels in Serum 1.2 Experimental: Grow
Publikováno v:
Growth Hormone & IGF Research. 8:167-170
Autor:
Peter C. Butler, T. L. Bianda, M. A. Hussain, J. S. Christiansen, Johannes D. Veldhuis, Birgit Nyholm, Ole Schmitz, E. R. Froesch, Niels Pørksen
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 272:E352-E358
Insulin-like growth factor I (IGF-I) shares structural and functional features with insulin, affects carbohydrate metabolism, and inhibits insulin secretion. Insulin secretion is pulsatile, and it is regulated by changing frequency and/or mass of sec
Publikováno v:
Scopus-Elsevier
Osteoblasts prepared from calvaria of newborn rats produce insulin-like growth factors (IGF) and IGF-binding proteins (IGFBP), IGFBP-5 was discovered in bone extracts. However, we could not detect IGFBP-5 in the medium of newborn rat osteoblasts, alt
Publikováno v:
Diabetes. 44:1209-1212
Treatment with insulin-like growth factor I (IGF-I) is accompanied by mild generalized and reversible edema. These changes may be due to increased capillary permeability. Therefore, we studied the effects of subcutaneous IGF-I treatment in healthy su
Publikováno v:
Journal of Clinical Investigation. 94:1126-1133
Insulin-like growth factor-I (IGF-I) is considered to be the mediator of the growth-promoting effects of growth hormone (GH). The metabolic effects of these two hormones, however, are different. Whereas GH treatment leads to elevated insulin and gluc
Autor:
M. Hussain, E. R. Froesch
Publikováno v:
Diabetologia. 37:S179-S185
Insulin-like growth factor I (IGF I) is an endocrine hormone that mediates most of the effects of pituitary growth hormone. Other important regulatory factors of serum IGF I levels are insulin and nutrition. Most of the circulating IGF I is bound to